Secondary Logo

Journal Logo

February-March 2013 - Volume 36 - Issue 2
pp: 79-157

Dendritic Cell–Based Immunotherapy in Prevention and Treatment of Renal Cell Carcinoma: Efficacy, Safety, and Activity of Ad-GM·CAIX in Immunocompetent Mouse Models

Birkhäuser, Frédéric D.; Koya, Richard C.; Neufeld, Caleb; More

Journal of Immunotherapy. 36(2):102-111, February-March 2013.

Sleeping Beauty System to Redirect T-cell Specificity for Human Applications

Maiti, Sourindra N.; Huls, Helen; Singh, Harjeet; More

Journal of Immunotherapy. 36(2):112-123, February-March 2013.

Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy

Morgan, Richard A.; Chinnasamy, Nachimuthu; Abate-Daga, Daniel; More

Journal of Immunotherapy. 36(2):133-151, February-March 2013.

Comparison of Glioma-associated Antigen Peptide-loaded Versus Autologous Tumor Lysate-loaded Dendritic Cell Vaccination in Malignant Glioma Patients

Prins, Robert M.; Wang, Xiaoyan; Soto, Horacio; More

Journal of Immunotherapy. 36(2):152-157, February-March 2013.